ALPS Medical Breakthroughs ETF ETF Analysis

ALPS Medical Breakthroughs ETF Profile

About ALPS Medical Breakthroughs ETF

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

ALPS Medical Breakthroughs ETF Sectors